GÜVENİR ÇELİK, E. And EROĞLU, O. 2021. The combination of ruxolitinib and MK2206 inhibits cell growth via activating P53 and PTEN expression and decreasing PI3K expression in triple negative breast cancer cell line. European Human Genetics Virtual Conference 2021 .

GÜVENİR ÇELİK, E., & EROĞLU, O., (2021). The combination of ruxolitinib and MK2206 inhibits cell growth via activating P53 and PTEN expression and decreasing PI3K expression in triple negative breast cancer cell line . European Human Genetics Virtual Conference 2021

GÜVENİR ÇELİK, ESİN, And ONUR EROĞLU. "The combination of ruxolitinib and MK2206 inhibits cell growth via activating P53 and PTEN expression and decreasing PI3K expression in triple negative breast cancer cell line," European Human Genetics Virtual Conference 2021, 2021

GÜVENİR ÇELİK, ESİN G. And EROĞLU, ONUR. "The combination of ruxolitinib and MK2206 inhibits cell growth via activating P53 and PTEN expression and decreasing PI3K expression in triple negative breast cancer cell line." European Human Genetics Virtual Conference 2021 , 2021

GÜVENİR ÇELİK, E. And EROĞLU, O. (2021) . "The combination of ruxolitinib and MK2206 inhibits cell growth via activating P53 and PTEN expression and decreasing PI3K expression in triple negative breast cancer cell line." European Human Genetics Virtual Conference 2021 .

@conferencepaper{conferencepaper, author={ESİN GÜVENİR ÇELİK And author={ONUR EROĞLU}, title={The combination of ruxolitinib and MK2206 inhibits cell growth via activating P53 and PTEN expression and decreasing PI3K expression in triple negative breast cancer cell line}, congress name={European Human Genetics Virtual Conference 2021}, city={}, country={}, year={2021}}